Sat.Feb 11, 2023 - Fri.Feb 17, 2023

article thumbnail

Senate hearing to examine bipartisan reforms to rein in middlemen

PhRMA

Did you know that insurance companies use middlemen — known as pharmacy benefit managers (PBMs) — to decide what medicines people can get and what people pay out of pocket for those medicines?

Insurance 298
article thumbnail

New-Onset Autoimmune Diagnoses After COVID-19

Drug Topics

Viruses are known to precipitate autoimmune diseases, but the link between COVID-19 and autoimmune conditions requires additional research.

266
266
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Current treatments for cramps aren’t cutting it. Why aren’t there better options?

STAT

One day last fall, Kiran’s period cramps became so painful they woke her up from a nap. The 19-year-old took some ibuprofen, but found little relief. “The pain was so bad, it felt like someone was punching me,” said Kiran, who asked to be referred to by only her first name for privacy. It felt “like I was giving birth.

145
145
article thumbnail

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork

Fierce Healthcare

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork hlandi Sat, 02/11/2023 - 05:02

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

12 supplements to lower your blood pressure

The Checkup by Singlecare

Lots of people love the idea of taking something natural to improve their health. For example, the idea of taking a supplement that could improve their blood pressure and reduce their chances of heart attack or cardiovascular disease may be very appealing. But how effective–and safe–is this strategy? Before you decide to start taking any supplements for their alleged antihypertensive effects, it’s important to understand what those supplements can and can’t do.

article thumbnail

Phase 3 Data Published for Zavegepant for the Acute Treatment of Migraine in Adults

Drug Topics

Nearly 40 million people in the United States suffer from migraine, with the World Health Organization classifying migraine as 1 of the 10 most disabling medical illnesses.

201
201

More Trending

article thumbnail

Weight loss jabs to be sold via high street chemists in England

The Guardian - Pharmaceutical Industry

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy Weekly weight-loss jabs that are popular with celebrities will soon be made available through high street chemists in England, despite controversy over their use. Many people struggle to tackle obesity through diet and exercise alone as they often find they regain the weight that they lose.

112
112
article thumbnail

Sun Pharma recalls at least 34,000 bottles of generic drug

Pharmafile

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, from the US market. The drug is used for treating high blood pressure, angina and some types of irregular heartbeat. This recall follows the FDA’s Enforcement Report, which saw “failed impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

FDA 115
article thumbnail

Mark Cuban Takes on PBMs at Association for Accessible Medicines Annual Meeting

Drug Topics

The founder of Mark Cuban Cost Plus Drug Company called drug pricing "insane" during a fireside chat at the Association of Accessible Medicines annual meeting.

187
187
article thumbnail

Opinion: The haunting brain science of long Covid

STAT

Matt Fitzgerald used to bike up and down 3,500 feet through the Santa Ana Mountains on three-hour rides just for fun. Now, nine months after being infected with SARS-CoV-2, the virus that causes Covid-19, he can’t muster walking on flat surfaces for 20 minutes without days of exhaustion. “My long Covid life remains terrifying,” he told me.

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg

Fierce Pharma

GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg esagonowsky Wed, 02/15/2023 - 09:02

140
140
article thumbnail

Senators question why PBMs 'even exist' in heated hearing amid push for reform

Fierce Healthcare

Senators question why PBMs 'even exist' in heated hearing amid push for reform rking Thu, 02/16/2023 - 14:49

144
144
article thumbnail

COVID-19 Vaccine Included in Updated CDC Vaccine Schedule for Children and Adolescents

Drug Topics

The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

Vaccines 187
article thumbnail

STAT+: CRISPR pioneer Feng Zhang launches new genetic delivery startup with $193 million

STAT

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading scientists in the groundbreaking field of genetic editing, had reached out two days prior to discuss a new company he was working on. Since helping to discover CRISPR-Cas9 — often referred to as molecular scissors that can cut into the genome and edit DNA — Zhang has founded at least

141
141
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit

Fierce Pharma

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit kdunleavy Tue, 02/14/2023 - 10:29

145
145
article thumbnail

GoodPop rolls out oatmilk-based frozen dessert bars

Drug Store News

The fudgy oat milk-based frozen dessert bars are available in four flavors — fudge n’ vanilla crunch, double chocolate fudge, fudge n’ caramel crunch and mint n’ fudge chip.

111
111
article thumbnail

ASHP President Urges Biden Administration to Utilize Pharmacists as Care Providers in Opioid Epidemic

Drug Topics

The letter outlined 7 steps that the Biden administration can take without the need for additional legislation.

187
187
article thumbnail

Opinion: The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word

STAT

Signing into law a change that can prevent thousands of Americans from dying of opioid overdoses should have been met with fanfare. Instead, it not only slid under the media radar but hasn’t been communicated to the people who need to know about it. Included in the end-of-year appropriations bill that President Biden signed on December 29, 2022 was the bipartisan Mainstreaming Addiction Treatment (MAT) Act of 2023.

article thumbnail

American Telemedicine Association announced 12 telehealth innovators challenge finalists

Fierce Healthcare

American Telemedicine Association announced 12 telehealth innovators challenge finalists aburky Fri, 02/17/2023 - 11:45

132
132
article thumbnail

What to do when exercise triggers hives

The Checkup by Singlecare

When someone claims to be allergic to exercise it might sound like a creative excuse to avoid working out. But for some, exercise can trigger a type of itchy skin rash, commonly known as exercise-induced hives (urticaria). It can be alarming to break out in red spots after breaking a sweat. Here’s what to know if it happens to you. What are exercise hives?

article thumbnail

Technology Trends to Prevent Prescription Errors

Drug Topics

Technology can streamline—and make safer—processes like medication reconciliation.

201
201
article thumbnail

A rare Marburg outbreak sparks a race against time to test vaccines and drugs

STAT

A Marburg fever outbreak in Equatorial Guinea is galvanizing efforts to test drugs and vaccines for a virus that currently has none. But every day counts, warned experts who gathered virtually on Tuesday to try to chart a course for the work. The outbreak is believed to have begun in early January, but the confirmation that the Marburg virus was responsible for the growing cluster of people sick with hemorrhagic-fever-like illness was only confirmed on Monday.

Vaccines 127
article thumbnail

Brian Fox is bringing ‘fresh eyes’ to ad agency Klick

PharmaVoice

Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

105
105
article thumbnail

Leading innovators in kidney disorder treatment compositions for the pharmaceutical industry

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Kidney disorder treatm

article thumbnail

New Year Begins With Hikes in Drug Prices

Drug Topics

The list prices of 450 medications have increased 5% overall, and more price hikes are expected.

187
187
article thumbnail

Opinion: Improving patient safety shouldn’t be a financial calculation

STAT

A recent study of medical error published in The New England Journal of Medicine reached a shocking conclusion about patient safety: Nearly a quarter century after a highly publicized Institute of Medicine report on the prevalence of patient harm sparked vows to cut the rate by half in five years , “in-hospital adverse events” remain so common that they affect roughly one in four patients.

Hospitals 115
article thumbnail

AARP leans into at-home care with Luna, providing its 38M members with in-person MSK care

Fierce Healthcare

AARP leans into at-home care with Luna, providing its 38M members with in-person MSK care aburky Wed, 02/15/2023 - 17:23

128
128
article thumbnail

Innovation in immuno-oncology: Leading companies in cancer monoclonal antibody therapy

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology: Leading companies in cancer monoclonal

article thumbnail

PBMs Under Fire at Senate Hearing

Drug Topics

Senators lobbed harsh criticisms at pharmacy benefit managers during a legislative hearing.

187
187
article thumbnail

STAT+: FDA approves first treatment for leading cause of blindness in older people

STAT

The Food and Drug Administration approved on Friday the first treatment for geographic atrophy, a progressive eye disease and a leading cause of blindness in older people. The new drug, called Syfovre, is made by Apellis Pharmaceuticals.

FDA 110
article thumbnail

Senate panel launches effort to shore up health workforce and ease crippling shortages

Fierce Healthcare

Senate panel launches effort to shore up health workforce and ease crippling shortages rking Thu, 02/16/2023 - 16:52

126
126
article thumbnail

Analytical platform could advance mRNA medicine QC

European Pharmaceutical Review

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines. The method is an important innovation for quality control ( QC) in production lines. The platform can elucidate mRNA sequences while quantifying ‘capping’ at one end of the molecule and the integrity of the tail on the other, all vital in mRNA pharmaceuticals.

article thumbnail

Some States Allowing Donation and Redistribution of Oncology Drugs

Drug Topics

Collections of oncology drugs in 13 states are being redistributed to patients in need.

187
187
article thumbnail

STAT+: Pfizer scraps half of participants in Lyme disease drug trial due to quality issues

STAT

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator. The companies disclosed Friday that violations of Good Clinical Practice, the international ethical and quality standards used by all clinical researchers, had been found at sites run by an undisclosed trial operator, leading Pfizer and Valneva to drop trial participants at those loca

Vaccines 110